<I>In-silico</I> Characterisation and Binding Affinity Evaluation of Hypothetical Proteins from <I>Trichophyton verrucosum</I> against Azole Antifungals and Natural Compounds
Trichophyton verrucosum is a pathogenic dermatophyte known to cause skin infections, particularly among individuals in close contact with livestock, such as farmers and veterinarians. Aim: This study presents an in-silico approach to identify and characterise novel therapeutic targets by focusing on functionally uncharacterized hypothetical proteins (HPs) from T. verrucosum . These HPs may play key roles in the pathogen’s biology and represent promising candidates for antifungal drug development. Materials and Methods: In the initial phase of the study, previously published data included 8028 proteins retrieved from NCBI, among which 6227 were annotated as hypothetical proteins (HPs). Conserved domain analysis revealed functional motifs in 4432 of these HPs. Non-homology screening against the human proteome yielded 1648 fungal-specific proteins, from which 51 essential proteins were predicted using the Geptop server. These essential proteins were further analysed for physicochemical properties, subcellular localisation, and structural features. Results: Most were cytoplasmic (~74.5%) and showed diverse isoelectric points, hydrophilic character, and amino acid compositions. Structural models were generated using the Phyre2 server, and eight stable proteins were selected based on ProtParam analysis for docking studies. Molecular docking with Ketoconazole, Clotrimazole, Terbinafine, and phytocompounds (Eugenol, 1,8-Cineole, Camphor) revealed strong binding affinity, particularly for Ketoconazole with XP_003018087.1 and XP_003018908.1. Major Findings: These findings suggest promising therapeutic targets in T. verrucosum and provide a basis for future structure-based antifungal drug development.